National Neuroscience Institute

This study looks at whether a simple genetic test can help doctors pick the right blood thinner for stroke patients. About 350 people who had a mild stroke or mini-stroke will be randomly assigned to either standard care or genetic testing. Those with a gene change that makes clo…

This study tests a drug called ACT001 in 12 adults whose glioblastoma (a severe brain cancer) has come back after standard treatment. Only patients with a specific genetic marker (STAT3-high) are included. The goal is to see if the drug can shrink or stabilize the tumor for at le…

This study tests whether a daily dose of tocotrienols (a form of vitamin E) can slow the worsening of Parkinson's disease symptoms. About 100 adults with Parkinson's will take either the supplement or a placebo for two years. Researchers will track changes in movement, thinking, …